Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Maker:
Pfizer
What it does:
Treats fungal infections, such as esophageal candidiasis
Traditional dosage:
For esophageal candidiasis, 200 mg in tablets or oral solution, every 12 hours, at least an hour before or after a meal. For other fungal infections, treatment starts with an intravenous infusion of 6 mg per kilogram of weight every 12 hours for the first 24 hours, followed by a maintenance dose of either 4 mg per kilogram of weight every 12 hours or 200 mg in tablets or oral solution every 12 hours. Duration of treatment varies according to the infection
Drug interactions, precautions, & recommendations:
Do not use with high-dose Norvir; use with caution with low-dose Norvir. Do not use with Saint-John’s-wort, ergot alkaloids, terfenadine, astemizole, cisapride, pimozide, quinidine, or rifabutin. Use with caution in patients with heart arrhythmias.
Side effects:
Most serious: severe liver problems, heart arrhythmias, visual disturbances Other: fever, nausea, rash, vomiting, chills, headache
Pfizer
What it does:
Treats fungal infections, such as esophageal candidiasis
Traditional dosage:
For esophageal candidiasis, 200 mg in tablets or oral solution, every 12 hours, at least an hour before or after a meal. For other fungal infections, treatment starts with an intravenous infusion of 6 mg per kilogram of weight every 12 hours for the first 24 hours, followed by a maintenance dose of either 4 mg per kilogram of weight every 12 hours or 200 mg in tablets or oral solution every 12 hours. Duration of treatment varies according to the infection
Drug interactions, precautions, & recommendations:
Do not use with high-dose Norvir; use with caution with low-dose Norvir. Do not use with Saint-John’s-wort, ergot alkaloids, terfenadine, astemizole, cisapride, pimozide, quinidine, or rifabutin. Use with caution in patients with heart arrhythmias.
Side effects:
Most serious: severe liver problems, heart arrhythmias, visual disturbances Other: fever, nausea, rash, vomiting, chills, headache
From our Sponsors
Most Popular
BREAKING: Supreme Court rules to save free access to preventive care, including PrEP
June 27 2025 10:32 AM
Thanks to U=U, HIV-positive people can live long, happy, healthy lives
July 25 2025 2:37 PM
The Talk: Beyond the exam room
August 13 2025 3:15 PM
Plus: Featured Video
Latest Stories
Amazing People of 2025: Javier Muñoz
October 17 2025 7:35 PM
It’s National PrEP Day! Learn the latest about HIV prevention
October 10 2025 9:00 AM
“I am the steward of my ship”: John Gibson rewrites his HIV narrative
September 16 2025 2:56 PM
“So much life to live”: Eric Nieves on thriving with HIV
September 03 2025 11:37 AM
The Talk: Owning your voice
August 25 2025 8:16 PM
The lab coat just got queer
August 21 2025 10:00 AM
Messenger RNA could be the key to an HIV vaccine — but government cuts pose a threat
August 20 2025 8:02 AM
The Talk: Navigating your treatment
August 01 2025 6:02 PM
The Talk: Starting the conversation
July 25 2025 4:47 PM
How the Black AIDS Institute continues to fill in the gaps
July 25 2025 1:06 PM
“I felt like a butterfly”: Niko Flowers on reclaiming life with HIV
July 23 2025 12:22 PM
Dancer. Healer. Survivor. DéShaun Armbrister is all of the above
July 02 2025 8:23 PM
1985: the year the AIDS crisis finally broke through the silence
June 26 2025 11:24 AM
VIDEO: A man living with HIV discusses his journey to fatherhood
June 10 2025 4:58 PM
Trump admin guts $258 million in funding for HIV vaccine research
June 03 2025 3:47 PM
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM


































































